{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:23:12Z","timestamp":1773692592044,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The impact of multi-drug resistant bacterial strains on human health is reaching worrisome levels. Over 2 million people are infected by resistant bacteria, and more than 700,000 people die each year because of the continuous spread of resistant strains. The development of new antibiotics and the prudent use of existing ones to prolong their lifespan require a constant effort by drug industries and healthcare workers. The re-purposing of existing drugs for use as antimicrobial agents would streamline the development of new antibacterial strategies. As part of this effort, we screened a panel of drugs previously characterized to be epigenetic modulators\/pro-apoptotic\/differentiative drugs. We selected a few compounds that alter Gram-positive growth. Among these, UVI5008, a derivative of the natural compound psammaplin A (Psa_A), was identified. The interaction of Psa_A with the DNA gyrase enzyme has been shown, and here, we hypothesized and confirmed the gyrase-specific activity by biochemical assays. UVI5008 exhibited growth inhibition activity against <jats:italic>Staphylococcus aureus<\/jats:italic> via structural modification of the cell wall, which was observed by SEM electron microscopy. Based on our findings, we propose UVI5008 as an alternative antibacterial compound against methicillin-resistant (Met.R) <jats:italic>S<\/jats:italic>. <jats:italic>aureus<\/jats:italic> strains.<\/jats:p>","DOI":"10.1038\/s41598-018-31135-9","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:10:12Z","timestamp":1535451012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Epigenetic modulator UVI5008 inhibits MRSA by interfering with bacterial gyrase"],"prefix":"10.1038","volume":"8","author":[{"given":"Gianluigi","family":"Franci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Folliero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcella","family":"Cammarota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Zannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Schiraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel R.","family":"de Lera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7312-5387","authenticated-orcid":false,"given":"Lucia","family":"Altucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Galdiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"31135_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/MMBR.00016-10","volume":"74","author":"J Davies","year":"2010","unstructured":"Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 74, 417\u2013433, https:\/\/doi.org\/10.1128\/MMBR.00016-10 (2010).","journal-title":"Microbiol Mol Biol Rev"},{"key":"31135_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature17042","volume":"529","author":"ED Brown","year":"2016","unstructured":"Brown, E. D. & Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 529, 336\u2013343, https:\/\/doi.org\/10.1038\/nature17042 (2016).","journal-title":"Nature"},{"key":"31135_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/PMC.S14459","volume":"6","author":"RJ Fair","year":"2014","unstructured":"Fair, R. J. & Tor, Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem 6, 25\u201364, https:\/\/doi.org\/10.4137\/PMC.S14459 (2014).","journal-title":"Perspect Medicin Chem"},{"key":"31135_CR4","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3389\/fmicb.2016.00470","volume":"7","author":"G Cheng","year":"2016","unstructured":"Cheng, G. et al. Antimicrobial Drugs in Fighting against Antimicrobial Resistance. Front Microbiol 7, 470, https:\/\/doi.org\/10.3389\/fmicb.2016.00470 (2016).","journal-title":"Front Microbiol"},{"key":"31135_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1128\/CMR.00027-10","volume":"24","author":"ER Sydnor","year":"2011","unstructured":"Sydnor, E. R. & Perl, T. M. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 24, 141\u2013173, https:\/\/doi.org\/10.1128\/CMR.00027-10 (2011).","journal-title":"Clin Microbiol Rev"},{"key":"31135_CR6","first-page":"999","volume":"66","author":"E Khan","year":"2016","unstructured":"Khan, E., Irfan, S., Sultan, B. A., Nasir, A. & Hasan, R. Dissemination and spread of New Delhi Metallo-beta-lactamase-1 Superbugs in hospital settings. J Pak Med Assoc 66, 999\u20131004 (2016).","journal-title":"J Pak Med Assoc"},{"key":"31135_CR7","first-page":"137","volume":"55","author":"AM Spagnolo","year":"2014","unstructured":"Spagnolo, A. M. et al. Staphylococcus aureus with reduced susceptibility to vancomycin in healthcare settings. J Prev Med Hyg 55, 137\u2013144 (2014).","journal-title":"J Prev Med Hyg"},{"key":"31135_CR8","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1016\/S1473-3099(16)00078-5","volume":"16","author":"A Zumla","year":"2016","unstructured":"Zumla, A. et al. Host-directed therapies for infectious diseases: current status, recent progress, and future prospects. Lancet Infect Dis 16, e47\u201363, https:\/\/doi.org\/10.1016\/S1473-3099(16)00078-5 (2016).","journal-title":"Lancet Infect Dis"},{"key":"31135_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1295-3","volume":"17","author":"SY Tong","year":"2016","unstructured":"Tong, S. Y. et al. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial. Trials 17, 170, https:\/\/doi.org\/10.1186\/s13063-016-1295-3 (2016).","journal-title":"Trials"},{"key":"31135_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5492\/wjccm.v5.i2.111","volume":"5","author":"E Paramythiotou","year":"2016","unstructured":"Paramythiotou, E. & Routsi, C. Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients. World J Crit Care Med 5, 111\u2013120, https:\/\/doi.org\/10.5492\/wjccm.v5.i2.111 (2016).","journal-title":"World J Crit Care Med"},{"key":"31135_CR11","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola, C. L. The antibiotic resistance crisis: part 1: causes and threats. P T 40, 277\u2013283 (2015).","journal-title":"P T"},{"key":"31135_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/003335491212700103","volume":"127","author":"TF Landers","year":"2012","unstructured":"Landers, T. F., Cohen, B., Wittum, T. E. & Larson, E. L. A review of antibiotic use in food animals: perspective, policy, and potential. Public Health Rep 127, 4\u201322, https:\/\/doi.org\/10.1177\/003335491212700103 (2012).","journal-title":"Public Health Rep"},{"key":"31135_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12941-017-0242-9","volume":"16","author":"V Sharma","year":"2017","unstructured":"Sharma, V. et al. Coagulase gene polymorphism, enterotoxigenecity, biofilm production, and antibiotic resistance in Staphylococcus aureus isolated from bovine raw milk in North West India. Ann Clin Microbiol Antimicrob 16, 65, https:\/\/doi.org\/10.1186\/s12941-017-0242-9 (2017).","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"31135_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1007\/s12272-015-0645-0","volume":"38","author":"ML Ang","year":"2015","unstructured":"Ang, M. L., Murima, P. & Pethe, K. Next-generation antimicrobials: from chemical biology to first-in-class drugs. Arch Pharm Res 38, 1702\u20131717, https:\/\/doi.org\/10.1007\/s12272-015-0645-0 (2015).","journal-title":"Arch Pharm Res"},{"key":"31135_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.2217\/epi.10.62","volume":"2","author":"G Franci","year":"2010","unstructured":"Franci, G., Miceli, M. & Altucci, L. Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer. Epigenomics 2, 731\u2013742, https:\/\/doi.org\/10.2217\/epi.10.62 (2010).","journal-title":"Epigenomics"},{"key":"31135_CR16","doi-asserted-by":"publisher","first-page":"e28737","DOI":"10.1371\/journal.pone.0028737","volume":"7","author":"CL Quave","year":"2012","unstructured":"Quave, C. L. et al. Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics. PLoS One 7, e28737, https:\/\/doi.org\/10.1371\/journal.pone.0028737 (2012).","journal-title":"PLoS One"},{"key":"31135_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/BF02976431","volume":"22","author":"D Kim","year":"1999","unstructured":"Kim, D., Lee, I. S., Jung, J. H. & Yang, S. I. Psammaplin A, a natural bromotyrosine derivative from a sponge, possesses the antibacterial activity against methicillin-resistant Staphylococcus aureus and the DNA gyrase-inhibitory activity. Arch Pharm Res 22, 25\u201329 (1999).","journal-title":"Arch Pharm Res"},{"key":"31135_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.antiviral.2015.09.002","volume":"123","author":"CH White","year":"2015","unstructured":"White, C. H. et al. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency. Antiviral Res 123, 78\u201385, https:\/\/doi.org\/10.1016\/j.antiviral.2015.09.002 (2015).","journal-title":"Antiviral Res"},{"key":"31135_CR19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/0959-437X(93)90002-7","volume":"3","author":"AM Campbell","year":"1993","unstructured":"Campbell, A. M. Genome organization in prokaryotes. Curr Opin Genet Dev 3, 837\u2013844 (1993).","journal-title":"Curr Opin Genet Dev"},{"key":"31135_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.2217\/epi-2016-0057","volume":"8","author":"N Cureau","year":"2016","unstructured":"Cureau, N., AlJahdali, N., Vo, N. & Carbonero, F. Epigenetic mechanisms in microbial members of the human microbiota: current knowledge and perspectives. Epigenomics 8, 1259\u20131273, https:\/\/doi.org\/10.2217\/epi-2016-0057 (2016).","journal-title":"Epigenomics"},{"key":"31135_CR21","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1128\/IAI.69.12.7610-7615.2001","volume":"69","author":"SM Julio","year":"2001","unstructured":"Julio, S. M. et al. DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae. Infect Immun 69, 7610\u20137615, https:\/\/doi.org\/10.1128\/IAI.69.12.7610-7615.2001 (2001).","journal-title":"Infect Immun"},{"key":"31135_CR22","doi-asserted-by":"publisher","first-page":"9467","DOI":"10.1021\/jm300618u","volume":"55","author":"R Pereira","year":"2012","unstructured":"Pereira, R. et al. Indole-derived psammaplin A analogues as epigenetic modulators with multiple inhibitory activities. J Med Chem 55, 9467\u20139491, https:\/\/doi.org\/10.1021\/jm300618u (2012).","journal-title":"J Med Chem"},{"key":"31135_CR23","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000063903","volume":"205","author":"M Pechere","year":"2002","unstructured":"Pechere, M., Germanier, L., Siegenthaler, G., Pechere, J. C. & Saurat, J. H. The antibacterial activity of topical retinoids: the case of retinaldehyde. Dermatology 205, 153\u2013158, https:\/\/doi.org\/10.1159\/000063903 (2002).","journal-title":"Dermatology"},{"key":"31135_CR24","doi-asserted-by":"publisher","first-page":"9408","DOI":"10.1074\/jbc.M112.419861","volume":"288","author":"J Sayegh","year":"2013","unstructured":"Sayegh, J. et al. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen. J Biol Chem 288, 9408\u20139417, https:\/\/doi.org\/10.1074\/jbc.M112.419861 (2013).","journal-title":"J Biol Chem"},{"key":"31135_CR25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/jrr\/rrt227","volume":"55","author":"T Oike","year":"2014","unstructured":"Oike, T., Ogiwara, H., Amornwichet, N., Nakano, T. & Kohno, T. Chromatin-regulating proteins as targets for cancer therapy. J Radiat Res 55, 613\u2013628, https:\/\/doi.org\/10.1093\/jrr\/rrt227 (2014).","journal-title":"J Radiat Res"},{"key":"31135_CR26","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1158\/1535-7163.MCT-11-0525","volume":"10","author":"A Nebbioso","year":"2011","unstructured":"Nebbioso, A. et al. Death receptor pathway activation and increase of ROS production by the triple epigenetic inhibitor UVI5008. Mol Cancer Ther 10, 2394\u20132404, https:\/\/doi.org\/10.1158\/1535-7163.MCT-11-0525 (2011).","journal-title":"Mol Cancer Ther"},{"key":"31135_CR27","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","volume":"45","author":"K Lewis","year":"2001","unstructured":"Lewis, K. Riddle of biofilm resistance. Antimicrob Agents Chemother 45, 999\u20131007, https:\/\/doi.org\/10.1128\/AAC.45.4.999-1007.2001 (2001).","journal-title":"Antimicrob Agents Chemother"},{"key":"31135_CR28","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S0090-4295(99)80074-0","volume":"45","author":"CK Lee","year":"1995","unstructured":"Lee, C. K., Rubin, L. G. & Moldwin, R. M. Synergy between protamine and vancomycin in the treatment of Staphylococcus epidermidis biofilms. Urology 45, 720\u2013724, https:\/\/doi.org\/10.1016\/S0090-4295(99)80074-0 (1995).","journal-title":"Urology"},{"key":"31135_CR29","doi-asserted-by":"publisher","unstructured":"Thieme, L. et al. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis. J Antimicrob Chemother, https:\/\/doi.org\/10.1093\/jac\/dky051 (2018).","DOI":"10.1093\/jac\/dky051"},{"key":"31135_CR30","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1089\/mdr.2014.0024","volume":"20","author":"W Elkhatib","year":"2014","unstructured":"Elkhatib, W. & Noreddin, A. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model. Microb Drug Resist 20, 575\u2013582, https:\/\/doi.org\/10.1089\/mdr.2014.0024 (2014).","journal-title":"Microb Drug Resist"},{"key":"31135_CR31","first-page":"12","volume":"82","author":"DC Hooper","year":"1987","unstructured":"Hooper, D. C., Wolfson, J. S., Ng, E. Y. & Swartz, M. N. Mechanisms of action of and resistance to ciprofloxacin. Am J Med 82, 12\u201320 (1987).","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"31135_CR32","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1086\/428052","volume":"41","author":"GA Jacoby","year":"2005","unstructured":"Jacoby, G. A. Mechanisms of resistance to quinolones. Clin Infect Dis 41(Suppl 2), S120\u2013126, https:\/\/doi.org\/10.1086\/428052 (2005).","journal-title":"Clin Infect Dis"},{"key":"31135_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2217\/fmb.15.24","volume":"10","author":"N Leeson","year":"2015","unstructured":"Leeson, N. & Hsueh, P. R. Antimicrobial resistance in the 21st century. Future Microbiol 10, 297\u2013298, https:\/\/doi.org\/10.2217\/fmb.15.24 (2015).","journal-title":"Future Microbiol"},{"key":"31135_CR34","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fmicb.2017.01518","volume":"8","author":"NF Kamaruzzaman","year":"2017","unstructured":"Kamaruzzaman, N. F. et al. Bactericidal and Anti-biofilm Effects of Polyhexamethylene Biguanide in Models of Intracellular and Biofilm of Staphylococcus aureus Isolated from Bovine Mastitis. Front Microbiol 8, 1518, https:\/\/doi.org\/10.3389\/fmicb.2017.01518 (2017).","journal-title":"Front Microbiol"},{"key":"31135_CR35","doi-asserted-by":"publisher","unstructured":"Roy, R., Tiwari, M., Donelli, G. & Tiwari, V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence, 0, https:\/\/doi.org\/10.1080\/21505594.2017.1313372 (2017).","DOI":"10.1080\/21505594.2017.1313372"},{"key":"31135_CR36","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1128\/JCM.37.6.1771-1776.1999","volume":"37","author":"H Ceri","year":"1999","unstructured":"Ceri, H. et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37, 1771\u20131776 (1999).","journal-title":"J Clin Microbiol"},{"key":"31135_CR37","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.tvjl.2005.01.006","volume":"171","author":"MB Melchior","year":"2006","unstructured":"Melchior, M. B., Vaarkamp, H. & Fink-Gremmels, J. Biofilms: a role in recurrent mastitis infections? Vet J 171, 398\u2013407, https:\/\/doi.org\/10.1016\/j.tvjl.2005.01.006 (2006).","journal-title":"Vet J"},{"key":"31135_CR38","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1128\/AAC.47.1.317-323.2003","volume":"47","author":"MC Walters III","year":"2003","unstructured":"Walters, M. C. 3rd., Roe, F., Bugnicourt, A., Franklin, M. J. & Stewart, P. S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother 47, 317\u2013323 (2003).","journal-title":"Antimicrob Agents Chemother"},{"key":"31135_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31, 455\u2013461, https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J Comput Chem"},{"key":"31135_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.mimet.2008.03.005","volume":"74","author":"P Knezevic","year":"2008","unstructured":"Knezevic, P. & Petrovic, O. A colorimetric microtiter plate method for assessment of phage effect on Pseudomonas aeruginosa biofilm. J Microbiol Methods 74, 114\u2013118, https:\/\/doi.org\/10.1016\/j.mimet.2008.03.005 (2008).","journal-title":"J Microbiol Methods"},{"key":"31135_CR41","doi-asserted-by":"publisher","first-page":"W147","DOI":"10.1093\/nar\/gkw419","volume":"44","author":"S Babicki","year":"2016","unstructured":"Babicki, S. et al. Heatmapper: web-enabled heat mapping for all. Nucleic Acids Res 44, W147\u2013153, https:\/\/doi.org\/10.1093\/nar\/gkw419 (2016).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31135-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:00:33Z","timestamp":1671613233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31135-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31135"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31135-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"1 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13117"}}